v3.26.1
STOCKHOLDERS' EQUITY
 6 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Share Repurchase Program
On February 15, 2024, the Company announced that the Board of Directors approved the repurchase of an additional $150 million in shares of common stock over a three year period. This authorization was an increase to the previous $150 million repurchase program approved in August 2021 and the previous $100 million repurchase programs approved in November 2018, February 2017, and February 2016. The repurchase program is set to expire in February 2027. Stock repurchases under this program may be made in the open market or in private transactions at times and in amounts determined by the Company. As of June 30, 2026, $93.2 million remained available under the program.
Common and Preferred Stock
The Board of Directors has the authority to issue common and unclassed preferred stock of up to 200 million shares and 25 million shares, respectively, with par value of $0.01 per share, as well as to fix dividends, voting and conversion rights, redemption provisions, liquidation preferences, and other rights and restrictions.
Accumulated Other Comprehensive Income (Loss)
Changes in AOCI by component, net of tax, for the six months ended June 30, 2026 are summarized as follows (in thousands):
Foreign Currency TranslationDerivative InstrumentsTotal
Balances at December 31, 2025$(1,237)$839 $(398)
Net unrealized (losses) gains arising during the period(a)
(315)1,757 1,442 
Less: Net realized gains reclassified to net loss (b)
— 789 789 
Net change during the period(315)968 653 
Balances at March 31, 2026(1,552)1,807 255 
Net unrealized gains (losses) arising during the period(c)
446 (3,203)(2,757)
Less: Net realized gains reclassified to net loss (d)
— 1,138 1,138 
Net change during the period446 (4,341)(3,895)
Balances at June 30, 2026$(1,106)$(2,534)$(3,640)
—————————
(a) Derivative instruments net of $0.4 million of tax liability for the three months ended March 31, 2026.
(b) Derivative instruments net of $0.2 million of tax liability for the three months ended March 31, 2026.
(c) Derivative instruments net of $0.8 million of tax benefit for the three months ended June 30, 2026.
(d) Derivative instruments net of $0.3 million of tax liability for the three months ended June 30, 2026.
Changes in AOCI by component, net of tax, for the six months ended June 30, 2025 are summarized as follows (in thousands):
Foreign Currency TranslationDerivative InstrumentsTotal
Balances at December 31, 2024$(2,999)$(230)$(3,229)
Net unrealized gains arising during the period(e)
167 409 576 
Less: Net realized losses reclassified to net loss(f)
— (203)(203)
Net change during the period167 612 779 
Balances at March 31, 2025(2,832)382 (2,450)
Net unrealized gains arising during the period(g)
1,180 1,396 2,576 
Less: Net realized gains reclassified to net income(h)
— 328 328 
Net change during the period1,180 1,068 2,248 
Balances at June 30, 2025$(1,652)$1,450 $(202)
—————————
(e) Derivative instruments net of $0.1 million of tax liability for the three months ended March 31, 2025.
(f) Derivative instruments net of $0.1 million of tax benefit for the three months ended March 31, 2025.
(g) Derivative instruments net of $0.5 million of tax liability for the three months ended June 30, 2025.
(h) Derivative instruments net of $0.1 million of tax liability for the three months ended June 30, 2025.